Lixte Biotech Hlds (LIXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,988 | -6,010 | -3,466 | -1,485 | -710 |
| Accounts payable and accrued liabilities | -45 | 381 | 96 | 36 | 57 |
| Other Working Capital | -102 | 413 | 111 | 41 | 41 |
| Other Operating Activity | 304 | 2,145 | 1,276 | 352 | 43 |
| Operating Cash Flow | $-1,831 | $-3,071 | $-1,983 | $-1,056 | $-569 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | N/A | -440 | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | -2,637 | -2,637 | N/A | N/A |
| Other Investing Activity | -25 | -2,733 | -2,637 | 0 | 0 |
| Investing Cash Flow | $-25 | $-3,173 | $-2,637 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 10,311 | 6,469 | 914 | 914 |
| Other Financing Activity | 0 | 0 | 0 | -10 | 0 |
| Financing Cash Flow | $N/A | $10,311 | $6,469 | $904 | $914 |
| Beginning Cash Position | 5,107 | 1,039 | 1,039 | 1,039 | 1,039 |
| End Cash Position | 3,251 | 5,107 | 2,888 | 887 | 1,385 |
| Net Cash Flow | $-1,856 | $4,068 | $1,849 | $-152 | $346 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,831 | -3,071 | -1,983 | -1,056 | -569 |
| Free Cash Flow | -1,831 | -3,071 | -1,983 | -1,056 | -569 |